We are live on ! Find out more
BW

Biegel & Waller Portfolio holdings

AUM $179M
1-Year Est. Return 1.6%
This Fund
S&P 500
This Quarter Est. Return
+5.51%
1 Year Est. Return
+1.6%
3 Year Est. Return
+28.22%
5 Year Est. Return
10 Year Est. Return
AUM
$196M
AUM Growth
+$1.14M
Cap. Flow
-$7.08M
Cap. Flow %
-3.62%
Top 10 Hldgs %
64.79%
Holding
82
New
5
Increased
16
Reduced
39
Closed
2

Top Buys

Rank Stock Value
1
CTLT
CATALENT, INC.
CTLT
+$2.04M
2
DOW icon
Dow Inc
DOW
+$1.34M
3
CTVA icon
Corteva
CTVA
+$681K
4
AMT icon
American Tower
AMT
+$336K
5
AXSM icon
Axsome Therapeutics
AXSM
+$176K

Sector Composition

Rank Sector Weight
1 Communication Services 10.3%
2 Industrials 8%
3 Financials 5.59%
4 Consumer Discretionary 3.21%
5 Healthcare 2.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRDN icon
76
Viridian Therapeutics
VRDN
$2.13B
$136K 0.07%
4,434
SIRI icon
77
SiriusXM
SIRI
$10B
$128K 0.07%
2,291
-300
-12% -$17.1K
LLEX
78
DELISTED
Lilis Energy, Inc. Common Stock
LLEX
$53K 0.03%
87,500
CYRN
79
DELISTED
CYREN Ltd.
CYRN
$41K 0.02%
1,182
OTIV
80
DELISTED
OTI On Track Innovations Ltd
OTIV
$4K ﹤0.01%
10,000
LLY icon
81
Eli Lilly
LLY
$1.07T
-1,561
Closed -$203K
AGN
82
DELISTED
Allergan plc
AGN
-11,807
Closed -$1.73M

Similar funds

Biegel & Waller's Q2 2019 Portfolio in Review

As of Q2 2019, Biegel & Waller held 82 positions worth $196M, up 0.59% from $194M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Biegel & Waller withdrew a net $7.08M in Q2 2019, closing 2 positions and reducing 39 holdings. Its most notable exit was Allergan plc, an estimated $1.73M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 10% of assets, up from 9% a quarter earlier, followed by Industrials and Financials.

Against the trend, Biegel & Waller opened a new position in CATALENT, INC. worth $2.41M.

  • Biegel & Waller's largest Q2 2019 buy was CATALENT, INC.: 44,500 shares worth $2.41M.
  • Biegel & Waller added most to iShares MSCI EAFE Min Vol Factor ETF in Q2 2019, an estimated $140K increase.
  • Biegel & Waller's biggest Q2 2019 reduction was Sinclair Inc, cutting an estimated $1.61M.
  • Biegel & Waller fully exited Allergan plc in Q2 2019, selling an estimated $1.73M.
  • Biegel & Waller's ten largest holdings make up 65% of its $196M portfolio in Q2 2019.
  • Biegel & Waller opened 5 new positions and closed 2 in Q2 2019.
  • Biegel & Waller's portfolio value rose 0.59% quarter-over-quarter to $196M.

Based on Biegel & Waller's 13F filing for Q2 2019, filed 23 Jul 2019.